首页> 外文期刊>Urologia internationalis >Laparoscopic Radiofrequency Ablation versus Partial Nephrectomy for cT1a Renal Tumors: Long-Term Outcome of 179 Patients
【24h】

Laparoscopic Radiofrequency Ablation versus Partial Nephrectomy for cT1a Renal Tumors: Long-Term Outcome of 179 Patients

机译:腹腔镜射频消融与部分肾切除术治疗cT1a肾肿瘤:179例患者的长期结果

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To compare the long-term functional and oncological results between laparoscopic radiofrequency ablation (LRFA) and laparoscopic partial nephrectomy (LPN) in selected clinical T1a (cT1a) renal tumor patients. Methods: We retrospectively analyzed the medical records of patients with cT1a renal tumors who had LRFA or LPN at our institution between February 2006 and February 2015. Student's t test was used to compare the perioperative data between the two groups. Survival analyses were calculated using the Kaplan Meier method. Results: A total of 179 patients were included in the study. Patients in the LRFA cohort were significantly older and had higher American Society of Anesthesiologists sore than in the LPN cohort. The LRFA group had a significantly lower mean blood loss than the LPN group (p = 0.03). The percent decrease of GFR in the LRFA group was significantly lower than in the LPN group (p = 0.021). The 5-year overall, cancer-specific and disease-free survival were 93.3 vs. 94.6%, 98.0 vs. 98.5% and 97.1 vs. 97.3%, for LRFA and LPN, respectively (all p value >0.05). Conclusions: The excellent perioperative results, long-term functional and oncological outcomes of LRFA confirm that this technique is safe, nephron sparing and oncologically effective for the treatment of cT1a renal tumors. (C) 2016 S. Karger AG, Basel
机译:目的:比较部分临床T1a(cT1a)肾肿瘤患者的腹腔镜射频消融(LRFA)和腹腔镜部分肾切除术(LPN)之间的长期功能和肿瘤学结果。方法:我们回顾性分析了2006年2月至2015年2月在我院接受LRFA或LPN治疗的cT1a肾肿瘤患者的病历。采用t检验比较两组的围手术期数据。使用Kaplan Meier方法计算生存分析。结果:总共179名患者被纳入研究。与LPN队列相比,LRFA队列中的患者年龄大得多,并且美国麻醉医师学会的酸痛程度更高。 LRFA组的平均失血量明显低于LPN组(p = 0.03)。 LRFA组的GFR降低百分比显着低于LPN组(p = 0.021)。 LRFA和LPN的5年总生存率,癌症特异性生存率和无病生存率分别为93.3%和94.6%,98.0%和98.5%和97.1%和97.3%(所有p值> 0.05)。结论:LRFA的优良围手术期效果,长期功能和肿瘤学结局证实了该技术安全,肾单位少且在肿瘤学上对cT1a肾肿瘤的治疗有效。 (C)2016 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号